These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 14201379)

  • 1. [SIGNIFICANCE OF CORTICOID DETERMINATIONS IN PLASMA].
    JAKOBSON T
    Fin Lakaresallsk Handl; 1964; 108():12-24. PubMed ID: 14201379
    [No Abstract]   [Full Text] [Related]  

  • 2. PERSISTENCE OF ABNORMAL PITUITARY-ADRENAL RELATIONSHIP IN PATIENTS WITH CUSING'S DISEASE PARTIALLY CORRECTED BY BILATERAL SUBTOTAL ADRENALECTOMY.
    DRUCKER WD; ROGINSKY MS; CHRISTY NP
    Am J Med; 1965 Apr; 38():522-30. PubMed ID: 14271739
    [No Abstract]   [Full Text] [Related]  

  • 3. A FOUR-DAY CORTICOTROPHIN-SUPPRESSION TEST. STUDIES IN CUSHING'S SYNDROME AND IN NON CUSHING SUBJECTS WITH RELATED SYMPTOMS.
    ERNEST I
    Acta Endocrinol (Copenh); 1965 Jan; 48():147-62. PubMed ID: 14254767
    [No Abstract]   [Full Text] [Related]  

  • 4. APPRAISAL OF ADRENOCORTICAL HYPERFUNCTION: PATIENTS WITH CUSHING'S SYNDROME OR "NON-ENDOCRINE" TUMORS.
    BROOKS RV; DUPRE J; GOGATE AN; MILLS IH; PRUNTY FT
    J Clin Endocrinol Metab; 1963 Aug; 23():725-36. PubMed ID: 14059549
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of dexamethasone suppression test to indicate bilateral adrenocortical hyperplasia in Cushing's syndrome.
    SILVERMAN SR; MARNELL RT; SHOLITON LJ; WERK EE
    J Clin Endocrinol Metab; 1963 Feb; 23():167-72. PubMed ID: 13992947
    [No Abstract]   [Full Text] [Related]  

  • 6. [TESTING OF THE FUNCTION OF THE PITUITARY GLAND AND THE ADRENAL GLANDS WITH METOPIRONE].
    GOTH E; POLLAK L
    Orv Hetil; 1963 Nov; 104():2077-80. PubMed ID: 14096901
    [No Abstract]   [Full Text] [Related]  

  • 7. [DIURNAL VARIATION IN THE EXCRETION OF STEROIDS IN THE URINE AND ITS SUPPRESSION BY CORTICOSTEROIDS].
    KAWAHARA K
    Nihon Naibunpi Gakkai Zasshi; 1964 Apr; 40():9-33. PubMed ID: 14151000
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE PITUITARY-ADRENOCORTICAL SYSTEM IN CUSHING'S SYNDROME].
    KRACHT J
    Verh Dtsch Ges Pathol; 1963; 47():280-5. PubMed ID: 14168369
    [No Abstract]   [Full Text] [Related]  

  • 9. [COMPARISON OF THE CHARACTERISTICS OF ADRENOCORTICAL HYPERFUNCTION IN SIMPLE OBESITY AND IN CUSHING'S SYNDROME].
    SCHTEINGART DE; GREGERMAN RY; CONN JW
    Dia Med; 1964 Apr; 36():306-7. PubMed ID: 14145602
    [No Abstract]   [Full Text] [Related]  

  • 10. A CLINICAL-BIOCHEMICAL-HISTOLOGIC CORRELATION IN HYPERADRENOCORTICISM CAUSED BY ACQUIRED ADRENOCORTICAL HYPERPLASIA.
    CARR HE; CURTIS GW; THORN GW
    Am J Surg; 1964 Jan; 107():123-35. PubMed ID: 14099485
    [No Abstract]   [Full Text] [Related]  

  • 11. [GENERAL CONSIDERATION ON TECHNOLOGY IN MEDICINE: ADRENAL FUNCTION TESTS; APPLICATION TO HYPERCORTICISM].
    TAYEAU F
    Laval Med; 1963 Oct; 34():942-53. PubMed ID: 14094399
    [No Abstract]   [Full Text] [Related]  

  • 12. [ASSOCIATION OF A PHEOCHROMOCYTOMA AND CUSHING TYPE HYPERCORTICISM WITH HYPERALDOSTERONURIA].
    BOURGOIGNIE J; DUPONT JC; NOIRET R
    Ann Endocrinol (Paris); 1964; 25():269-84. PubMed ID: 14169426
    [No Abstract]   [Full Text] [Related]  

  • 13. CUSHING'S SYNDROME: NODULAR CORTICAL HYPERPLASIA OF ADRENAL GLANDS WITH CLINICAL AND PATHOLOGICAL FEATURES SUGGESTING ADRENOCORTICAL TUMOR.
    KIRSCHNER MA; POWELL RD; LIPSETT MB
    J Clin Endocrinol Metab; 1964 Oct; 24():947-55. PubMed ID: 14228534
    [No Abstract]   [Full Text] [Related]  

  • 14. CUSHING'S DISEASE AND POST-ADRENALECTOMY HYPERPIGMENTATION.
    MULLICAN WS
    J Indiana State Med Assoc; 1964 Apr; 57():331-5. PubMed ID: 14136833
    [No Abstract]   [Full Text] [Related]  

  • 15. [DIAGNOSIS AND TREATMENT OF CUSHING'S SYNDROME].
    JENNY M
    Schweiz Med Wochenschr; 1964 Nov; 94():1586-91. PubMed ID: 14340252
    [No Abstract]   [Full Text] [Related]  

  • 16. AN ALTERATION IN CORTISOL METABOLISM IN PATIENTS WITH CUSHING'S SYNDROME AND BILATERAL ADRENAL HYPERPLASIA.
    GUIGNARD-DEMAEYER JA; CRIGLER JF; GOLD NI
    J Clin Endocrinol Metab; 1963 Dec; 23():1271-84. PubMed ID: 14087608
    [No Abstract]   [Full Text] [Related]  

  • 17. ADRENOCORTICAL HYPERFUNCTION AND POTASSIUM METABOLISM IN PATIENTS WITH "NON- ENDOCRINE" TUMORS AND CUSHING'S SYNDROME.
    PRUNTY FT; BROOKS RV; DUPRE J; GIMLETTE TM; HUTCHINSON JS; MCSWINEY RR; MILLS IH
    J Clin Endocrinol Metab; 1963 Aug; 23():737-46. PubMed ID: 14059550
    [No Abstract]   [Full Text] [Related]  

  • 18. Cushing's syndrome associated with a "corticotrophin"-producing bronchial neoplasm neoplasm (results of corticotrophin assays and of pituitary-adrenal function tests).
    Landon J; James VH; Peart WS
    Acta Endocrinol (Copenh); 1967 Oct; 56(2):321-32. PubMed ID: 4293813
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma dehydroepiandrosterone sulfate in normal and pathological conditions.
    Yamaji T; Ibayashi H
    J Clin Endocrinol Metab; 1969 Feb; 29(2):273-8. PubMed ID: 4303580
    [No Abstract]   [Full Text] [Related]  

  • 20. [PLETHORIC OBESITY].
    FOSSATI P
    Lille Med; 1963; 8():SUPPL1039-52. PubMed ID: 14103606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.